Text Size
61 studies found for:    Gd-DTPA

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		Multihance at 3 Tesla in Brain Tumors
Condition: Brain Tumor
Interventions: Drug: Multihance;   Drug: Arm 2 - Magnevist
2 Completed Magnevist Post-marketing Surveillance in Japan
Condition: Diagnostic Imaging
Intervention: Drug: Gadopentetate dimeglumine (Magnevist, BAY86-4882)
3 Recruiting Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI
Condition: Hepatocellular Carcinoma
Intervention: Drug: gadobenate dimeglumine (MultiHance)
4 Completed Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography
Conditions: Magnetic Resonance Angiography;   Peripheral Vascular Diseases;   Peripheral Arterial Diseases
Intervention: Drug: Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)
5 Terminated
Has Results 		Safety and Efficacy of MultiHance in Pediatric Patients
Condition: Central Nervous System Diseases
Intervention: Drug: gadobenate dimeglumine
6 Completed Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries
Condition: Carotid, Aortic, Renal or Peripheral Artery Disease
Interventions: Drug: Gadobenate Dimeglumine;   Drug: Gadopentetate Dimeglumine
7 Completed Magnevist (SH L 451A) Intra-Individual Dose Comparison Study in Patients With Brain Metastasis
Condition: Brain Neoplasms
Intervention: Drug: Magnevist (SH L 451A)
8 Completed
Has Results 		Contrast-enhanced MRI in Children 2 Months to <2 Years
Condition: Magnetic Resonance Imaging
Intervention: Drug: Gadopentetate dimeglumine (Magnevist, BAY86-6661)
9 Completed Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries
Condition: Peripheral Vascular Disease
Intervention: Drug: Gadopentetate dimeglumine (Magnevist, BAY86-4882)
10 Completed Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain
Condition: Brain Lesions
Interventions: Drug: MULTIHANCE:;   Drug: GADOVIST
11 Completed Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects
Condition: Healthy
Interventions: Drug: Gadopentetate dimeglumine (Magnevist, BAY86-4882);   Drug: Moxifloxacin (BAY12-8039);   Drug: Placebo
12 Completed Multihance Versus Magnevist in Breast MRI
Condition: Breast Cancer
Interventions: Drug: Multihance;   Drug: Magnevist
13 Completed Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral Branches
Condition: Cardiovascular Abnormalities
Intervention: Drug: Gadopentetate dimeglumine (Magnevist)
14 Completed Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal Arteries
Condition: Stenosis
Intervention: Drug: Gadopentetate dimeglumine (Magnevist)
15 Completed Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction
Condition: Myocardial Infarction
Intervention: Drug: Magnevist (Gadopentetate dimeglumine, BAY86-4882)
16 Completed Crossover Study With MultiHance vs a Comparator for Peripheral MRA
Condition: Peripheral Vascular Disease
Interventions: Drug: MultiHance;   Drug: Magnevist
17 Completed Magnevist® Injection-Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries
Condition: Renal Artery Stenosis
Intervention: Drug: Gadopentetate dimeglumine (Magnevist)
18 Completed A Pharmacokinetics Study of MultiHance in Pediatric Patients
Condition: Central Nervous System Pathology
Intervention: Drug: Multihance
19 Completed Gadobutrol Magnevist-controlled Body Study
Condition: Magnetic Resonance Imaging
Interventions: Drug: Gadobutrol (Gadovist, BAY86-4875);   Drug: Gadopentetate Dimeglumine (Magnevist, BAY86-4882)
20 Completed Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Conditions: Diagnostic Imaging;   Central Nervous System Diseases
Interventions: Drug: Dotarem (gadoterate meglumine);   Drug: Magnevist (gadopentetate dimeglumine)
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years